At present, the company has more than 0/000 employees, 0/0 large dosage forms, 96 varieties, 0/78 product specifications and 26 production lines, forming a powerful product cluster such as small-volume injections, freeze-drying agents, powder injections, mixtures, capsules and tablets. It is a comprehensive pharmaceutical enterprise with complete pharmaceutical dosage forms and varieties in Central and South China. Among them, the production and sales scale of antibiotics ranks first in the country and first in the province; Kangfuxin liquid, a strategic key product of traditional Chinese medicine, is one of the varieties of traditional Chinese medicine with sales exceeding 100 million in Hunan Province. In 20 15 years, there were *** 17 varieties in Hunan pharmaceutical industry, and Hunan Kelun Yueyang Branch accounted for 2 varieties. In the next five years, Hunan Kelun new drug plate will build more than 10 single products with sales scale exceeding 100 million.
The company now has 98 patents and two provincial-level innovation platforms, and has been recognized as a high-tech enterprise in Hunan Province. Was awarded successively? Private enterprises in Hunan province/top 0/00 in kloc? 、? Hunan Environmental Integrity Enterprise? And then what? A national model enterprise with harmonious labor relations? And other honorary titles.
The development of enterprises can only be innovation. National second-class protected varieties of traditional Chinese medicine and famous trademarks of Hunan Province? Study on Quality Control System of Tianshu Xinkangfu New Liquid? Won the second prize of scientific and technological progress in Hunan Province; The newly developed parecoxib sodium 20 13 for injection has been brought into the industrial field of Hunan province? 100 key new product promotion plans? Key new product research and development projects; Ligustrazine hydrochloride for injection was recognized as a national key new product by the Ministry of Science and Technology. As a representative project of the pharmaceutical industry in Hunan Province, the company's new drug product industrialization project is listed as a key scheduling project of the governor of Hunan Province. 2065438+June 2005? New drug variety research and development and industrialization promotion project? Approved by the provincial party Committee and the provincial government? Made in China 2025? Action, the first batch of key projects to build a strong manufacturing province in Hunan.
Kelun Pharmaceutical Co., Ltd. took the lead in launching and implementing the Laboratory Information Management System (LIMS) project in the whole group, using computer system to manage and analyze the data of the experiment to ensure the accuracy and traceability of the experiment. 2065438+September 2005, Kelun Pharmaceutical won the honor of the Ministry of Industry and Information Technology? 20 15 national industrial enterprise quality benchmark? .
Second, the company's development plan
Thirteenth Five-Year Plan? During this period, Hunan Kelun plans to build 10 billion enterprises. In the next five years, Yueyang Branch will invest 2-3 billion yuan to add more than 10 production lines. It is estimated that more than 50 new drug varieties will be approved. These new drugs cover specialized therapeutic fields, such as anti-tumor, anti-virus (HBV), mental and nervous system diseases and diabetes drugs. Taking the research and development and industrialization of new drug delivery systems such as albumin nanoparticles, liposomes, microspheres and microcrystals in NDDS as innovation points, the targeted treatment of tumors is realized, and the technical content and market share of products are improved; At the same time, focusing on the new rehabilitation liquid, we will strengthen in-depth development, increase the secondary development of indications and new dosage forms, expand functional fields such as medicine and health care, build a breeding base in Tengchong, Yunnan, and improve the characteristic industrial chain of modern Chinese medicine; Two five-year plans, and strive to achieve operating income of over 10 billion in 2025.
Thirteenth Five-Year Plan? In the first year of 20 16, Hunan Kelun Pharmaceutical Research Co., Ltd. settled in Yueyang Economic Development Zone. At present, the developed drugs of 1 18 will be settled in the Economic Development Zone, among which 7 varieties and specifications of 10 have been clinically approved, entered the clinical trial stage and will be listed soon. At the same time, the pharmaceutical research branch undertakes the research and development, pilot scale-up and industrialization of new drugs of Kelun Pharmaceutical, and forms Kelun Group with Sichuan Kelun Pharmaceutical Research Co., Ltd., Tianjin Kelun Pharmaceutical Research Co., Ltd., Suzhou Kelun Pharmaceutical Research Co., Ltd. and American Pharmaceutical Research Branch. Five in one? R&D system will become an important part of Kelun Group's R&D system.
In 20 16, Yueyang branch plans to invest10.2 billion yuan to build four pilot production lines of freeze-dried powder injection, small-volume injection and solid preparation. The project will start at the end of July 20 16 and is expected to be completed in the first quarter of 20 17.
Third, the process of becoming bigger and stronger needs more soft services.
The establishment and growth of Hunan Kelun Yueyang Branch has received excellent services from provinces, cities, districts and various functional departments. However, to become the first drug dealer in Hunan, a century-old shop needs more support from all levels and departments and more soft services such as preferential policies.
1, leading and supporting scientific and technological innovation
Hunan Kelun has two production bases in Yueyang, producing different kinds of Chinese and western medicines. The two production bases account separately and pay taxes to the local government independently.
In recent years, the company is committed to developing new drug delivery systems, including nanoparticles, liposomes, microcrystals, etc., to achieve anti-tumor targeted therapy; At the same time, the company has filed and accepted hundreds of patents in recent years, and invested a lot of manpower, material resources and financial resources in scientific and technological innovation, but it can only be declared as a subject in project declaration, and only one declaration is accepted every year. Therefore, new technologies cannot be effectively promoted and given due attention.
It is hoped that the relevant functional departments of the municipal government will equally include the two production bases in 37 designated assistance targets in Yueyang City, get recommendation and support in the application of scientific and technological innovation and other projects, and enjoy the national project support policy. Give strong support in the declaration of scientific and technological progress awards, key new product projects and provincial quality awards.
2. Open up a green channel for new project construction.
According to Kelun Pharmaceutical's new drug research and development process, there will be more than ten new drug research and development pilots in 20 16, which need to be tested at the end of the year. Therefore, the anti-tumor pilot line construction project must be started in July this year, and the civil construction will be completed at 10. After discussion with the project design unit, it is proposed to adopt the method of overall design, batch drawing and step-by-step construction, but this method will delay the drawing time that meets the construction application conditions until September this year.
In order to ensure the smooth start of the project and put it into production as scheduled, we urge the Economic Development Zone Coordination and Planning Bureau, Housing and Construction Bureau, Municipal Fire Brigade and other relevant departments to open a green channel for the preliminary capital construction of the project.
3.cash? Back two into three? Policy difficulties
Former Hunan Zhongnan Kelun Pharmaceutical Co., Ltd. responded to the implementation of the municipal party committee and municipal government? Back two into three? With the call of the policy, the overall relocation was completed by the end of 20 12. The old factory is located in the east of Desheng South Road and south of Jin 'e West Road. Due to many reasons, it has not been listed for sale so far, and the benefits and policies that enterprises should enjoy cannot be fulfilled. Request the government's key support and hold a special meeting to coordinate and solve it.
4. Support the introduction of talents and fully enjoy preferential policies.
20 16 Yueyang branch responded to the government? The whole world? Policy, accelerated the introduction of talents, * * * introduced more than 80 talents with bachelor degree or above, including graduate students 15. But most of them are fresh graduates, and some of them are international students. Because there are not many preferential policies to settle in Yueyang, it is difficult to attract them to contribute to Yueyang for a long time. Therefore, it is suggested that the municipal government introduce preferential policies for scientific and technological personnel to enjoy public rental housing first and implement graded preferential policies.
Legal Representative: Liu Weiqiang.
Date of establishment: 20 12-04-25
Registered capital:
Location: Hunan Province
Unified social credit code: 9 1430600595464823J
Business status: surviving (in business, in business, on record)
Industry: manufacturing industry
Company type: branch of a limited liability company (invested or controlled by a natural person)
Personnel size: 5000-9999 people
Address: Qixi East Road, Kang Wang Industrial Park, Yueyang Economic and Technological Development Zone.
Scope: Engage in business dealings within the company's business scope. (Projects subject to approval according to law can only be operated after approval by relevant departments)